Validation of the VACTERL Episignature and Evidence for Epigenomic Convergence Across Recurrent Constellations of Embryonic Malformations
Postma, J. K.; Haghshenas, S.; Bily, T. M.; Isovic, M.; White-Brown, A.; McConkey, H.; Kerkhof, J.; Rzasa, J.; Saleh, M.; Prasad, C.; Siu, V. M.; Carter, M. T.; Dyment, D. A.; Lazier, J.; Sawyer, S. L.; Moresco, A. A.; Jimena Diaz, M.; Abbate, S. L.; Campeau, P. M.; Innes, A. M.; Boycott, K. M.; Sadikovic, B.; Balci, T. B.
Show abstract
Background: Recurrent constellations of embryonic malformations (RCEMs) comprise multiple malformation conditions with largely unexplained etiologies and no established molecular biomarkers. A shared DNA methylation episignature was recently identified in VACTERL association and oculoauriculovertebral spectrum (OAVS). We sought to validate this episignature in an independent, deeply phenotyped cohort and evaluate its detection across related RCEMs. Methods: Genome-wide DNA methylation profiling was performed on peripheral blood from 38 participants with clinically diagnosed RCEMs, including VACTERL (n=21), partial VACTERL (n=3), OAVS (n=3), and other RCEM-related conditions (n=11). Results: The Episign V5 RCEM episignature demonstrated robust sensitivity for VACTERL (18/21, 85.7% positive), while the remaining three participants showed intermediate positivity. Of three participants with partial VACTERL, one with tracheoesophageal fistula demonstrated intermediate positivity, whereas the other two were negative. Episignature positivity was also identified in oculoauriculofrontonasal dysplasia (1/1, robust) and rhomboencephalosynapsis (1/2, robust) but was limited in OAVS (1/3, intermediate) and absent in frontonasal dysplasia (0/4). Conclusions: Independent validation establishes the Episign V5 RCEM episignature as a reproducible molecular biomarker for VACTERL, a condition that remains a diagnosis of exclusion. Variable detection across related malformation conditions suggests etiologic heterogeneity, whereas overlap among selected phenotypes supports epigenomic convergence across the RCEM spectrum.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Rare variants found in multiplex families with orofacial clefts: Does expanding the phenotype make a difference? 95%
- Next-generation phenotyping in Nigerian children with Cornelia de Lange Syndrome 93%
- Known pathogenic gene variants and new candidates detected in Sudden Unexpected Infant Death using Whole Genome Sequencing 93%
Similar papers in this journal
- Genome Sequencing and Comprehensive Rare Variant Analysis of 465 Families with Neurodevelopmental Disorders 93%
- Exome copy number variant detection, analysis and classification in a large cohort of families with undiagnosed rare genetic disease 93%
- The impact of 22q11.2 copy number variants on human traits in the general population 92%
Similar papers in this journal
- Advancing Genotype-Phenotype Analysis through 3D Facial Morphometry: Insights from Cri-du-Chat Syndrome 93%
- Clinical description, molecular delineation and genotype-phenotype correlation in 340 patients with KBG syndrome: Addition of 67 new patients 92%
- Cerebral Visual Impairment: genetic diagnoses and phenotypic associations 92%
Similar papers in this journal
Similar papers in this journal
- BCL11A intellectual developmental disorder: defining the clinical spectrum and genotype-phenotype correlations 95%
- Polycomb-associated and Trithorax-associated developmental conditions – phenotypic convergence and heterogeneity 93%
- Structural variant calling and clinical interpretation in 6224 unsolved rare disease exomes 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.